Want to join the conversation?
$MYL and Biocon said the European Medicines Agency (EMA) has accepted for review, $MYL's Marketing Authorization Application (MAA) for proposed biosimilar Pegfilgrastim. Pegfilgrastim is prescribed for cancer patients to help them with some of the side-effects of their chemotherapy treatment.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.